ONP: Leaner, Meaner In 2006
This article was originally published in The Tan Sheet
Executive Summary
Director of the Office of Nonprescription Products Charles Ganley, MD, and Assistant Director Susan Johnson, PhD, met with industry stakeholders at a conference Feb. 1 to present an overview of the status of ONP in 2006. The department heads discussed FDA's plans to set a final deadline on monograph clearance and improve internal communication and NDA review, and made several suggestions on how industry can help FDA do its job..
You may also be interested in...
P&G Should Clean Up Vicks Early Defense Hand Sanitizer Claims, Labels – FDA
Product claims and labeling for Procter & Gamble's Vicks Early Defense Foaming Hand Sanitizer are not allowed under FDA's tentative final mono-graphs for OTC health care and first aid antiseptics, according to the agency
P&G Should Clean Up Vicks Early Defense Hand Sanitizer Claims, Labels – FDA
Product claims and labeling for Procter & Gamble's Vicks Early Defense Foaming Hand Sanitizer are not allowed under FDA's tentative final mono-graphs for OTC health care and first aid antiseptics, according to the agency
Congressional ’07 Budget Proposal Would Limit CDER Capabilities – FDA
President Bush's 2008 budget request for FDA includes spending $11.2 million more than proposed in Congress' 2007 omnibus spending bill for a "modernizing drug safety" initiative, including work by offices within the Center for Drug Evaluation and Research
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: